NRAS and cutaneous melanoma: A review of literature reports that 14 % of mucosal melanomas harbor activating c-KIT mutations; 5 % showed BRAF mutation and 14 % oncogenic mutations in NRAS, which is much lower than the reported BRAF prevalence (56–59 %) in cutaneous melanoma [25].